D. Rouzaud

516 total citations
9 papers, 44 citations indexed

About

D. Rouzaud is a scholar working on Surgery, Rheumatology and Immunology. According to data from OpenAlex, D. Rouzaud has authored 9 papers receiving a total of 44 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Rheumatology and 3 papers in Immunology. Recurrent topics in D. Rouzaud's work include Systemic Lupus Erythematosus Research (3 papers), Infectious Diseases and Tuberculosis (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). D. Rouzaud is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Infectious Diseases and Tuberculosis (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). D. Rouzaud collaborates with scholars based in France and Belgium. D. Rouzaud's co-authors include Karim Sacré, T. Papo, Rachid Abbas, Anne Boutten, Brigitte Escoubet, Monique Dehoux, C. David, Gillian Divard, Tiphaine Goulenok and Augustin Gaudemer and has published in prestigious journals such as Neurology, Clinica Chimica Acta and Autoimmunity Reviews.

In The Last Decade

D. Rouzaud

9 papers receiving 44 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Rouzaud France 5 17 12 11 9 9 9 44
Mélanie Roriz France 4 11 0.6× 15 1.3× 9 0.8× 4 0.4× 10 1.1× 9 43
Ludovic Tréfond France 4 19 1.1× 9 0.8× 11 1.0× 2 0.2× 7 0.8× 9 57
Sheila Melchor Spain 4 25 1.5× 14 1.2× 10 0.9× 2 0.2× 38 4.2× 8 66
Ahya Ali United States 4 5 0.3× 8 0.7× 4 0.4× 9 1.0× 8 0.9× 12 61
P. Smets France 3 12 0.7× 5 0.4× 3 0.3× 4 0.4× 19 2.1× 11 45
Justine Noel United States 4 8 0.5× 10 0.8× 10 0.9× 8 0.9× 9 1.0× 6 51
Parichat Uea‐Areewongsa Thailand 3 41 2.4× 17 1.4× 9 0.8× 9 1.0× 5 0.6× 5 59
Clara Pecoraro Italy 4 15 0.9× 3 0.3× 12 1.1× 5 0.6× 3 0.3× 6 49
Alfredo Iardino United States 5 4 0.2× 12 1.0× 8 0.7× 9 1.0× 25 2.8× 16 67
Anaïs Dartevel France 3 11 0.6× 4 0.3× 16 1.5× 11 1.2× 14 1.6× 6 69

Countries citing papers authored by D. Rouzaud

Since Specialization
Citations

This map shows the geographic impact of D. Rouzaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Rouzaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Rouzaud more than expected).

Fields of papers citing papers by D. Rouzaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Rouzaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Rouzaud. The network helps show where D. Rouzaud may publish in the future.

Co-authorship network of co-authors of D. Rouzaud

This figure shows the co-authorship network connecting the top 25 collaborators of D. Rouzaud. A scholar is included among the top collaborators of D. Rouzaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Rouzaud. D. Rouzaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Goulenok, Tiphaine, Augustin Gaudemer, D. Rouzaud, et al.. (2021). Infliximab to Treat Severe Paradoxical Reaction in HIV-Negative Tuberculous Meningoencephalitis. Neurology. 98(3). 118–119. 4 indexed citations
2.
Cohen‐Aubart, Fleur, Serge Doan, Éric Jouvent, et al.. (2021). Brain magnetic resonance imaging lesion load at diagnosis, severity at onset and outcomes in Susac syndrome: A prospective cohort study. European Journal of Neurology. 29(1). 121–129. 6 indexed citations
3.
Eshagh, Déborah, Khadija Benali, Antoine Dossier, et al.. (2020). Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient. Infection. 48(5). 799–802. 6 indexed citations
4.
Rohmer, Julien, Ludovic Tréfond, Yann Nguyen, et al.. (2020). Caractéristiques cliniques et évolution à long-terme des périartérite noueuses systémiques diagnostiquées depuis 2005. La Revue de Médecine Interne. 41. A33–A34. 1 indexed citations
5.
Dossier, Antoine, Arthur Mageau, Tiphaine Goulenok, et al.. (2020). Thromboses artérielles et infection COVID-19. La Revue de Médecine Interne. 41. A10–A10. 1 indexed citations
6.
Rohmer, Julien, Matthieu Groh, Jonathan London, et al.. (2019). Distal ischemia as the initial presentation of hypereosinophilic syndrome-related arterial involvement: A case study and literature review. Autoimmunity Reviews. 18(8). 828–830. 5 indexed citations
7.
David, C., Gillian Divard, Rachid Abbas, et al.. (2019). Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease. Clinica Chimica Acta. 493. S84–S84. 4 indexed citations
8.
David, C., Gillian Divard, Rachid Abbas, et al.. (2019). Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease. Scandinavian Journal of Rheumatology. 49(1). 33–37. 16 indexed citations
9.
Rouzaud, D., Jean‐François Alexandra, Antoine Dossier, et al.. (2016). Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study. Journal of Thrombosis and Thrombolysis. 42(3). 329–335. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026